
GenSight Biologics
Develops innovative therapies for mitochondrial and neurodegenerative diseases.
Market cap
$29.5m
Enterprise value
$43m
Share price
€0.20 SIGHT.PA
Company register number
751164757
Authorizing premium user...
Develops innovative therapies for mitochondrial and neurodegenerative diseases.